Efficacy and Safety of Pemigatinib in Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)
Public ClinicalTrials.gov record NCT03822117. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy and safety of pemigatinib in participants with previously treated locally advanced/metastatic or surgically unresectable solid tumor malignancies harboring activating FGFR mutations or translocations.
Study identification
- NCT ID
- NCT03822117
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 111 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 17, 2019 (Actual)
- Primary completion
- Mar 29, 2022 (Actual)
- Completion
- Mar 29, 2022 (Actual)
- Last update posted
- Nov 4, 2025
2019 – 2022
United States locations
- U.S. sites
- 44
- U.S. states
- 24
- U.S. cities
- 44
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cancer Treatment Centers of America | Goodyear | Arizona | 85338 | — |
| Mayo Clinic Hospital | Phoenix | Arizona | 85054 | — |
| The University of Arizona Cancer Center | Tucson | Arizona | 85724 | — |
| Chao Family Comprehensive Cancer Center University of California, Irvine | Orange | California | 92868 | — |
| Stanford Cancer Center | Palo Alto | California | 94304 | — |
| John Wayne Cancer Institute | Santa Monica | California | 90404 | — |
| St. Joseph Heritage Healthcare | Santa Rosa | California | 95403 | — |
| Florida Cancer Specialists & Research Institute | Fort Myers | Florida | 33901 | — |
| Mayo Clinic Jacksonville | Jacksonville | Florida | 32224 | — |
| Florida Cancer Specialists | St. Petersburg | Florida | 33705 | — |
| Florida Cancer Specialists | Tallahassee | Florida | 32308 | — |
| Florida Cancer Specialists | West Palm Beach | Florida | 33401 | — |
| Illinois Cancer Specialists | Arlington Heights | Illinois | 60005 | — |
| Edward H Kaplan & Associates | Skokie | Illinois | 60076 | — |
| Carle Cancer Center | Urbana | Illinois | 61801 | — |
| Cancer Treatment Centers of America | Zion | Illinois | 60099 | — |
| Indiana University Health - Arnett Cancer Care | Lafayette | Indiana | 47904 | — |
| University of Iowa | Iowa City | Iowa | 52242 | — |
| University of Kansas Cancer Center | Westwood | Kansas | 66205 | — |
| Ochsner Clinic | New Orleans | Louisiana | 70121 | — |
| Central Maine Medical Center | Lewiston | Maine | 04240 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Umass Memorial Medical Center, Inc. | Worcester | Massachusetts | 01655 | — |
| Mayo Clinic Rochester | Rochester | Minnesota | 55905 | — |
| Comprehensive Cancer Centers of Nevada | Las Vegas | Nevada | 89148 | — |
| Dartmouth Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | — |
| Summit Medical Group | Florham Park | New Jersey | 07932 | — |
| Winthrop University Hospital | Mineola | New York | 11501 | — |
| Oncology Specialists of Charlotte | Charlotte | North Carolina | 28204 | — |
| Duke Cancer Center | Durham | North Carolina | 27710 | — |
| Wake Forest Baptist Medical Center | Winston-Salem | North Carolina | 27157 | — |
| Stephenson Cancer Center | Oklahoma City | Oklahoma | 73104 | — |
| Southwestern Regional Medical Center | Tulsa | Oklahoma | 74133 | — |
| Cancer Institute of Greenville Health System | Greenville | South Carolina | 29605 | — |
| The West Clinic Pc | Germantown | Tennessee | 38138 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | — |
| Houston Methodist Hospital | Houston | Texas | 77030 | — |
| Joe Arrington Cancer Center | Lubbock | Texas | 79410 | — |
| Virginia Cancer Specialists, Pc | Fairfax | Virginia | 22031 | — |
| Virginia Oncology Associates-Lake Wright | Norfolk | Virginia | 23502 | — |
| Seattle Cancer Care Alliance | Seattle | Washington | 98109 | — |
| Multicare Institute For Research & Innovation | Tacoma | Washington | 98405 | — |
| West Virginia University Hospitals Inc | Morgantown | West Virginia | 26506 | — |
| University of Wisconsin Carbone Cancer Center | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 46 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03822117, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 4, 2025 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03822117 live on ClinicalTrials.gov.